180 related articles for article (PubMed ID: 9260252)
1. Immune response to Escherichia coli O157:H7 in hemolytic uremic syndrome following salmonellosis.
Flores FX; Jabs K; Thorne GM; Jaeger J; Linshaw MA; Somers MJ
Pediatr Nephrol; 1997 Aug; 11(4):488-90. PubMed ID: 9260252
[TBL] [Abstract][Full Text] [Related]
2. Humoral immune responses to Shiga-like toxins and Escherichia coli O157 lipopolysaccharide in hemolytic-uremic syndrome patients and healthy subjects.
Greatorex JS; Thorne GM
J Clin Microbiol; 1994 May; 32(5):1172-8. PubMed ID: 8051241
[TBL] [Abstract][Full Text] [Related]
3. Shiga toxin-producing Escherichia coli infection and antibodies against Stx2 and Stx1 in household contacts of children with enteropathic hemolytic-uremic syndrome.
Ludwig K; Sarkim V; Bitzan M; Karmali MA; Bobrowski C; Ruder H; Laufs R; Sobottka I; Petric M; Karch H; Müller-Wiefel DE
J Clin Microbiol; 2002 May; 40(5):1773-82. PubMed ID: 11980959
[TBL] [Abstract][Full Text] [Related]
4. Saliva IgM and IgA are a sensitive indicator of the humoral immune response to Escherichia coli O157 lipopolysaccharide in children with enteropathic hemolytic uremic syndrome.
Ludwig K; Grabhorn E; Bitzan M; Bobrowski C; Kemper MJ; Sobottka I; Laufs R; Karch H; Müller-Wiefel DE
Pediatr Res; 2002 Aug; 52(2):307-13. PubMed ID: 12149511
[TBL] [Abstract][Full Text] [Related]
5. Escherichia coli O157:H7 and O157:H(-) strains that do not produce Shiga toxin: phenotypic and genetic characterization of isolates associated with diarrhea and hemolytic-uremic syndrome.
Schmidt H; Scheef J; Huppertz HI; Frosch M; Karch H
J Clin Microbiol; 1999 Nov; 37(11):3491-6. PubMed ID: 10523540
[TBL] [Abstract][Full Text] [Related]
6. A biotyping scheme for Shiga-like (Vero) toxin-producing Escherichia coli O157 and a list of serological cross-reactions between O157 and other gram-negative bacteria.
Aleksić S; Karch H; Bockemühl J
Zentralbl Bakteriol; 1992 Jan; 276(2):221-30. PubMed ID: 1559010
[TBL] [Abstract][Full Text] [Related]
7. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.
Ake JA; Jelacic S; Ciol MA; Watkins SL; Murray KF; Christie DL; Klein EJ; Tarr PI
Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195
[TBL] [Abstract][Full Text] [Related]
8. Hemolytic uremic syndrome due to Escherichia coli O157: H7 in a child with multiple infections.
Ornt DB; Griffin PM; Wells JG; Powell KR
Pediatr Nephrol; 1992 May; 6(3):270-2. PubMed ID: 1616838
[TBL] [Abstract][Full Text] [Related]
9. Hemolytic-Uremic Syndrome and Escherichia coli O121 at a Lake in Connecticut, 1999.
McCarthy TA; Barrett NL; Hadler JL; Salsbury B; Howard RT; Dingman DW; Brinkman CD; Bibb WF; Cartter ML
Pediatrics; 2001 Oct; 108(4):E59. PubMed ID: 11581467
[TBL] [Abstract][Full Text] [Related]
10. Multiplex real-time PCR assay for detection of Escherichia coli O157:H7 and screening for non-O157 Shiga toxin-producing E. coli.
Li B; Liu H; Wang W
BMC Microbiol; 2017 Nov; 17(1):215. PubMed ID: 29121863
[TBL] [Abstract][Full Text] [Related]
11. Hemolytic uremic syndrome and diarrhea in Argentine children: the role of Shiga-like toxins.
Lopez EL; Diaz M; Grinstein S; Devoto S; Mendilaharzu F; Murray BE; Ashkenazi S; Rubeglio E; Woloj M; Vasquez M
J Infect Dis; 1989 Sep; 160(3):469-75. PubMed ID: 2668430
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of a recombinant Intimin, EspB and Shiga toxin 2B vaccine in calves experimentally challenged with Escherichia coli O157:H7.
Martorelli L; Garimano N; Fiorentino GA; Vilte DA; Garbaccio SG; Barth SA; Menge C; Ibarra C; Palermo MS; Cataldi A
Vaccine; 2018 Jun; 36(27):3949-3959. PubMed ID: 29807709
[TBL] [Abstract][Full Text] [Related]
13. Isolation of an Escherichia coli O157:H7 strain producing Shiga toxin 1 but not Shiga toxin 2 from a patient with hemolytic uremic syndrome in Korea.
Kim YB; Okuda J; Matsumoto C; Morigaki T; Asai N; Watanabe H; Nishibuchi M
FEMS Microbiol Lett; 1998 Sep; 166(1):43-8. PubMed ID: 9741083
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of infections with Shiga-like toxin-producing Escherichia coli by use of enzyme-linked immunosorbent assays for Shiga-like toxins on cultured stool samples.
Law D; Hamour AA; Acheson DW; Panigrahi H; Ganguli LA; Denning DW
J Med Microbiol; 1994 Apr; 40(4):241-5. PubMed ID: 8151673
[TBL] [Abstract][Full Text] [Related]
15. Prevalence, virulence profiles, and clinical significance of Shiga toxin-negative variants of enterohemorrhagic Escherichia coli O157 infection in humans.
Friedrich AW; Zhang W; Bielaszewska M; Mellmann A; Köck R; Fruth A; Tschäpe H; Karch H
Clin Infect Dis; 2007 Jul; 45(1):39-45. PubMed ID: 17554698
[TBL] [Abstract][Full Text] [Related]
16. A clinical and bacteriological study of children suffering from haemolytic uraemic syndrome in Tucuman, Argentina.
Miceli S; Jure MA; de Saab OA; de Castillo MC; Rojas S; de Holgado AP; de Nader OM
Jpn J Infect Dis; 1999 Apr; 52(2):33-7. PubMed ID: 10816611
[TBL] [Abstract][Full Text] [Related]
17. Verocytotoxin-producing Escherichia coli infection in household members of children with hemolytic-uremic syndrome in The Netherlands.
Heuvelink AE; Van de Kar NC; Van Der Velden TJ; Chart H; Monnens LA
Pediatr Infect Dis J; 1999 Aug; 18(8):709-14. PubMed ID: 10462341
[TBL] [Abstract][Full Text] [Related]
18. Serogroup-specific bacterial engineered glycoproteins as novel antigenic targets for diagnosis of shiga toxin-producing-escherichia coli-associated hemolytic-uremic syndrome.
Melli LJ; Ciocchini AE; Caillava AJ; Vozza N; Chinen I; Rivas M; Feldman MF; Ugalde JE; Comerci DJ
J Clin Microbiol; 2015 Feb; 53(2):528-38. PubMed ID: 25472487
[TBL] [Abstract][Full Text] [Related]
19. Soluble Fas and soluble Fas-ligand in children with Escherichia coli O157:H7-associated hemolytic uremic syndrome.
Masri C; Proulx F; Toledano B; Clermont MJ; Mariscalco MM; Seidman EG; Carcillo J
Am J Kidney Dis; 2000 Oct; 36(4):687-94. PubMed ID: 11007669
[TBL] [Abstract][Full Text] [Related]
20. Escherichia coli O157 fails to induce a long-lasting lipopolysaccharide-specific, measurable humoral immune response in children with hemolytic-uremic syndrome.
Ludwig K; Bitzan M; Bobrowski C; Müller-Wiefel DE
J Infect Dis; 2002 Aug; 186(4):566-9. PubMed ID: 12195387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
